Clinical effect analysis of 16 cases of laparoscopic anatomical hepatic segment Ⅷ resection
10.3760/cma.j.cn113884-20230224-00049
- VernacularTitle:腹腔镜解剖性肝Ⅷ段切除16例临床效果分析
- Author:
Changcheng TAO
1
;
Fan WU
;
Weiqi RONG
;
Liming WANG
;
Xuan MENG
;
Jianxiong WU
;
Hongguang WANG
Author Information
1. 国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院肝胆外科，北京 100021
- Keywords:
Carcinoma, hepatocellular;
Anatomical hepatectomy;
Liver segment Ⅷ;
Clinical effect
- From:
Chinese Journal of Hepatobiliary Surgery
2023;29(5):328-332
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the clinical effect of laparoscopic anatomical hepatic segment Ⅷ (S8) resection.Methods:Of 16 patients with liver cancer who underwent laparoscopic anatomical hepatic S8 resection at the National Cancer Center from October 2020 to October 2022 were were enrolled, including 13 males and 3 females, aged (59.1±10.9) years. The operation time, intraoperative blood loss, occurrence of intraoperative blood transfusion, and postoperative complications were retrospectively analyzed. Recurrence and survival were followed up by outpatient and telephone reviews.Results:Laparoscopic anatomical hepatic S8 resection was successfully performed in 16 patients without conversion to laparotomy. Among them, 10 patients underwent the intraoperative ultrasound guided hepatic parenchymal approach, and 6 underwent laparoscopic Glissonean pedicle puncture for the positive staining of S8 using indocyanine green. The operation time was (274.8±82.8) min, and the intraoperative blood loss was [ M( Q1, Q3)] 100.0 (50.0, 200.0) ml. There were no intraoperative blood transfusion or postoperative complication. The drainage tube was successfully removed and the patients were discharged 5 to 7 days after surgery. The patients were followed up for 5 to 24 months and all survived. Two patients had tumor recurrence. Conclusion:Laparoscopic anatomical S8 resection is safe and feasible.
